Evaluation of synergistic interactions between cell-free supernatant of Lactobacillus strains and Amikacin and genetamicin against Pseudomonas aeruginosa

Jundishapur Journal of Microbiology

Volumn 8, Issue 4, 2015, Pages

  Aminnezhad, Sargol ^a   Kermanshahi, Rouha Kasra ^b   Ranjbar, Reza ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ALZAHRA UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Checkerboard method; Lactobacillus casei; Lactobacillus rhamnosus; Pseudomonas aeruginosa

Indexed keywords

ACETIC ACID; AMIKACIN; AZITHROMYCIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; HYDROGEN PEROXIDE; IMIPENEM; LACTIC ACID; PROBIOTIC AGENT; TOBRAMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL FREE SUPERNATANT; CELL FREE SYSTEM; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FRACTIONAL INHIBITORY CONCENTRATION; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUPERNATANT;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; PSEUDOMONAS AERUGINOSA;

EID: 84929206689     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.8(4)2015.16592     Document Type: Article

References (52)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154(5):1229–56.
2. Vojtova V, Kolar M, Hricova K, Uvizl R, Neiser J, Blahut L, et al. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units. New Microbiol. 2011;34(3):291–8.
3. Khalil H, Chen T, Riffon R, Wang R, Wang Z. Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52(5):1635–41.
4. Ibezim EC, Esimone CO, Okorie O, Onyishi IV, Nnamani PO, Brown SA, et al. A study of the in-vitro interaction of co-trimoxazole and ampicillin using the checke board method. Afr J Biotechnol. 2006;5:1284–8.
5. Hermann T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci. 2007;64(14):1841–52.
6. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th edSt. Louis: Mosby; 2002.
7. Rishi P, Preet S, Kaur P. Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy. Ann Clin Microbiol Antimicrob. 2011;10:9.
8. Bergonzelli GE, Blum S, Brussow H, Corthesy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases? Digestion. 2005;72(1):57–68.
9. Gibbs PA. Novel uses for lactic acid fermentation in food preservation. Appl Bacteriol. 1987;63:51–8.
10. Huang L, Forsberg CW, Gibbins LN. Influence of External pH and Fermentation Products on Clostridium acetobutylicum Intracellular pH and Cellular Distribution of Fermentation Products. Appl Environ Microbiol. 1986;51(6):1230–4.
11. Byczkowski JZ, Gessner T. Biological role of superoxide ion-radical. Int J Biochem. 1988;20(6):569–80.
12. Jamalifar H, Rahimi H, Samadi N, Shahverdi A, Sharifian Z, Hosseini F, et al. Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol. 2011;3(1):21–5.
13. Percival M. Choosing a probiotic supplement. Clin Nutr Insights. 1997;6:1–4.
14. Valdez JC, Peral MC, Rachid M, Santana M, Perdigon G. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005;11(6):472–9.
15. Gan BS, Kim J, Reid G, Cadieux P, Howard JC. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J Infect Dis. 2002;185(9):1369–72.
16. Rishi P, Kaur S, Bhalla MPS, Preet S, Tiwari RP. Selection of probiotic Lactobacillus acidophilus and its prophylactic activity against murine Salmonellosis. Int J Pro Pre. 2008;3(2):89–98.
17. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol. 2004;70(1):518–26.
18. Rybak MJ, McGrath BJ. Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician. Drugs. 1996;52(3):390–405.
19. Clinical and Laboratory Standards Institute.. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6 th ed. approved standard editor. Wayne: CLSI; 2003.
20. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493–6.
21. Anderson EL, Gramling PK, Vestal PR, Farrar WJ. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother. 1975;8(3):300–4.
22. Ogunbanwo ST, Sanni AI, Onilude AA. Characterization of bacteriocin produced by Lactobacillus plantarum F1 and Lactobacillus brevis OG1. Afr J Biotechnol. 2003;2(8):219–27.
23. Nitisinprasert S, Nilphai V, Bunyun P, Sukyai P, Doi K, Sonomoto K. Screening and identification of effective thermotolerant lactic acid bacteria producing antimicrobial activity against Escherichia coli and Salmonella sp.resistant to antibiotics. Kasetsart J. 2000;34(3):387–400.
24. European committee for antimicrobial susceptibility testing. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents.: Eucast; 2000.
25. Coda R, Cassone A, Rizzello CG, Nionelli L, Cardinali G, Gobbetti M. Antifungal activity of Wickerhamomyces anomalus and Lactobacillus plantarum during sourdough fermentation: identification of novel compounds and long-term effect during storage of wheat bread. Appl Environ Microbiol. 2011;77(10):3484–92.
26. Sanchez-Machado DI, Lopez-Cervantes J, Martinez-Cruz O. Quantification of organic acids in fermented shrimp waste by HPLC. Food Technol. Biotechnol. 2008;46(4):456–60.
27. Abdallah OM, Badawey AM. Derivative Ratio Spectrophotometric, Chemometric and HPLC Validated methods for Simultaneous Determination of amlodipine and atorvastatin in combined dosage form. Int J Ind Chem. 2011;2(2):78–85.
28. De Keersmaecker SC, Verhoeven TL, Desair J, Marchal K, Vanderleyden J, Nagy I. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol Lett. 2006;259(1):89–96.
29. Luzzaro F, Mantengoli E, Perilli M, Lombardi G, Orlandi V, Orsatti A, et al. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol. 2001;39(5):1865–70.
30. Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev. 2005;105(2):477–98.
31. Bryan LE, O'Hara K, Wong S. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984;26(2):250–5.
32. Galbraith L, Wilkinson SG, Legakis NJ, Genimata V, Katsorchis TA, Rietschel ET. Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa. Ann Microbiol (Paris). 1984;135B(2):121–36.
33. Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science. Am J Infect Control. 2006;34(2):84–93.
34. Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis to solid substrata by an adsorbed biosurfactant layer from Lactobacillus acidophilus. Urology. 1997;49(5):790–4.
35. Vodnar DC, Paucean A, DULF FV, Socaciu C. HPLC characterization of lactic acid formation and FTIR fingerprint of probiotic bacteria during fermentation processes. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 2010;38(2):109–13.
36. Yang Z. Antimicrobial compounds and extracellular polysaccharides produced by lactic acid bacteria: structures and properties.Finland: department of food technology, University of Helsinki; 2000.
37. Smulders FJM, Barendsen P, Van Logtestijn JG, Mossel DAA, Van Der Marel GM. Review: Lactic acid: considerations in favour of its acceptance as a meat decontamininant. Int J Food Sci Technol. 2007;21(4):419–36.
38. Earnshaw RG. The antimicrobial action of lactic acid bacteria: natural food preservation systems. In: Wood BJB editor. The Lactic Acid Bacteria. UK: Springer; 1992. pp. 211–32.
39. Kong S, Davison AJ. The role of interactions between O2, H2 O2,• OH, e- and O2- in free radical damage to biological systems. Arch Biochem Biophys. 1980;204(1):13–29.
40. Alakomi HL, Skytta E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol. 2000;66(5):2001–5.
41. Goswami M, Mangoli SH, Jawali N. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother. 2006;50(3):949–54.
42. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hormannsperger G, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164–85.
43. Snydman DR. The safety of probiotics. Clin Infect Dis. 2008;46 Suppl 2:S104–11.
44. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84(3):197–215.
45. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect. 2005;11(12):958–66.
46. Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24(1):31–40.
47. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38(4):457–8.
48. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005;24(3):278–80.
49. Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. Int J STD AIDS. 2006;17(4):280–2.
50. Kalima P, Masterton RG, Roddie PH, Thomas AE. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect. 1996;32(2):165–7.
51. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 2004;12(9):412–6.
52. Mathur S, Singh R. Antibiotic resistance in food lactic acid bacteria--a review. Int J Food Microbiol. 2005;105(3):281–95.